UK Markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
283.63-3.89 (-1.35%)
At close: 04:00PM EST
283.50 -0.13 (-0.05%)
After hours: 07:10PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3311.88
52-week low 3187.16
50-day moving average 3287.27
200-day moving average 3240.31

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 3862.15k
Shares outstanding 5144M
Implied shares outstanding 6N/A
Float 8143.56M
% held by insiders 10.70%
% held by institutions 187.31%
Shares short (13 Oct 2022) 42.5M
Short ratio (13 Oct 2022) 41.05
Short % of float (13 Oct 2022) 41.95%
Short % of shares outstanding (13 Oct 2022) 41.72%
Shares short (prior month 14 Sept 2022) 42.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 27.64%
Operating margin (ttm)28.54%

Management effectiveness

Return on assets (ttm)7.60%
Return on equity (ttm)20.23%

Income statement

Revenue (ttm)10.36B
Revenue per share (ttm)70.97
Quarterly revenue growth (yoy)-9.70%
Gross profit (ttm)8.87B
EBITDA 3.49B
Net income avi to common (ttm)2.86B
Diluted EPS (ttm)19.29
Quarterly earnings growth (yoy)244.70%

Balance sheet

Total cash (mrq)4.91B
Total cash per share (mrq)34.1
Total debt (mrq)6.63B
Total debt/equity (mrq)51.96
Current ratio (mrq)2.49
Book value per share (mrq)70.93

Cash flow statement

Operating cash flow (ttm)2.4B
Levered free cash flow (ttm)2.31B